首页> 外文期刊>Nuclear Medicine and Biology >Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.
【24h】

Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.

机译:N,N'-双(3-氨基丙基)-N,N'-二甲基乙二胺衍生的亲脂性和单阳离子镓放射性药物的合成和生物分布:68Ga对PET心肌成像的潜在作用。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: In locations that lack nearby cyclotron facilities for radionuclide production, generator-based (68)Ga radiopharmaceuticals might have clinical utility for positron emission tomography (PET) studies of myocardial perfusion and other physiological processes. METHODS: The lipophilic and monocationic (67)Ga-labeled gallium chelates of five novel hexadentate bis(salicylaldimine) ligands the bis(salicylaldimine), bis(3-methoxysalicylaldimine), bis(4-methoxysalicylaldimine), bis(6-meth,oxysalicylaldimine), and bis(4,6-dimethoxysalicylaldimine) of N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine (BAPDMEN), were prepared. The structure of the unlabeled [Ga(4-MeOsal)(2)BAPDMEN](+)PF(6)(-) salt was determined by X-ray crystallography, and the biodistribution of each of the (67)Ga-labeled gallium chelates was determined in rats following intravenous administration and compared with the biodistribution of [(86)Rb]rubidium chloride. RESULTS: The [Ga(4-MeOsal)(2)BAPDMEN](+)PF(6)(-) complex exhibited the expected pseudo-octahedral N(4)O(2)(2-) coordination sphere about the Ga(3+) center with a trans disposition of the phenolate oxygen atoms. All five (67)Ga radiopharmaceuticals were found to afford the desired myocardial retention of the radiogallium. The [(67/68)Ga][Ga(3-MeOsal)(2)BAPDMEN](1+) radiopharmaceutical appears to have the best properties for myocardial imaging, exhibiting 2% of the injected dose in the heart 1 min and 2 h postinjection and very high heartontarget ratios (heart/blood ratios of 7.6+/-1.0 and 54+/-10 at 1 and 120 min, respectively; heart/liver ratios of 1.8+/-0.4 and 39+/-3 at 1 and 120 min, respectively). CONCLUSIONS: Most of these new agents, particularly [(67/68)Ga][Ga(3-MeOsal)(2)BAPDMEN](1+), would appear superior to previously reported bis(salicylaldimine) ligands of N,N'-bis(3-aminopropyl)ethylenediamine as candidates for PET imaging of the heart with (68)Ga.
机译:简介:在附近没有回旋加速器生产放射性核素的地方,基于发生器的(68)Ga放射性药物可能在临床上可用于对心肌灌注和其他生理过程进行正电子发射断层扫描(PET)研究。方法:亲脂性和单阳离子(67)Ga标记的镓螯合物的五个新的六齿双(水杨醛亚胺)配体双(水杨醛亚胺),双(3-甲氧基水杨醛亚胺),双(4-甲氧基水杨醛亚胺),双(6-甲基,氧水杨基醛亚胺) ),并制备N,N′-双(3-氨基丙基)-N,N′-二甲基乙二胺(BAPDMEN)的双(4,6-二甲氧基水杨醛亚胺)。通过X射线晶体学测定未标记的[Ga(4-MeOsal)(2)BAPDMEN](+)PF(6)(-)盐的结构,以及(67)Ga标记的镓各自的生物分布在静脉内给药后在大鼠中确定螯合物,并与[(86)Rb]氯化rub的生物分布进行比较。结果:[Ga(4-MeOsal)(2)BAPDMEN](+)PF(6)(-)配合物表现出预期的伪Ga(4)O(2)(2)(2-)配位球3+)中心带有酚盐氧原子的转位。发现所有五种(67)Ga放射性药物都能提供所需的放射性镓心肌保留。 [(67/68)Ga] [Ga(3-MeOsal)(2)BAPDMEN](1+)放射性药物似乎具有最佳的心肌成像性能,在心脏1分钟和2分钟内显示出2%的注射剂量h注射后和非常高的心脏/非靶标比率(在1和120分钟时心脏/血液比率分别为7.6 +/- 1.0和54 +/- 10;心脏/肝脏比率为1.8 +/- 0.4和39 +/- 3分别在1分钟和120分钟)。结论:大多数这些新药,特别是[(67/68)Ga] [Ga(3-MeOsal)(2)BAPDMEN](1+),似乎比先前报道的N,N'的双(水杨醛亚胺)配体更好。 -双(3-氨基丙基)乙二胺作为(68)Ga对心脏进行PET成像的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号